Back

Introduction, recap and overview of evidence for SGLT2 inhibitors in HFrEF.

27 August 2022 (15:30 - 15:45)
Organised by:
Congress Presentation Part of: SGLT2 inhibitors in practice (part 3): the case for early intervention in HFrEF Heart Failure with Reduced Ejection Fraction (HFrEF) Open Access ESC Congress 2022

About the speaker

Photo
Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

2 More presentations in this session

Presentation thumbnail
Implementing an SGLT2i for HFrEF treatment in my practice.
Professor A. Stewart Coats (Sydney, AU)
Slides Video
Presentation thumbnail
Panel discussion.
Professor S. Anker (Berlin, DE)
Slides Video

Access the full session

Session thumbnail
SGLT2 inhibitors in practice (part 3): the case for early intervention in HFrEF
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 15:30 CET
You may be interested in
thumbnail
Congress Session
Overcoming clinical inertia in chronic heart failure care - SGLT2 inhibition across the spectrum of ejection fraction
20 May 2023
thumbnail
Congress Presentation
A closer look at heart failure drugs: particular benefits and problems.
28 August 2022
thumbnail
Congress Presentation
Welcome and introduction.
26 August 2022
thumbnail
Congress Presentation
What is the evidence for SGLT2 inhibitors in HF?
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources